"The insights from the work have formed the foundation of a new pipeline. They have helped with positioning and concepts of current products. We have also transformed how we engage with project teams, management teams and across the entire category. We delivered the key insights to win, along with the clarity of the consumer journey using short documentary videos and VR films. A new bar was set for R&D consumer research."

— Global R&D, Director Consumer Innovation Science

"The films are being used as part of an on-going customer closeness programme for our sales and marketing force. They have provided fantastic insight into the lifestyles of one of our key segments. Naked Eye worked under tight timelines and delivered great work. It was extremely well received by the team and the Marketing Directors at our headquarters in Los Angeles."

— Marketing Director, a global apparel company

"The insights we’ve gained from Naked Eye has fundamentally changed the way we market our product. They will add approximately £6m to my sales over the next 12 months."

— Pharmaceutical Brand Manager

"Naked Eye's work literally took clinicians and commissioners into the world and lives of the population. This resulted in fundamental changes in communication styles and access channels to services."

— Marketing Director

"The outputs delivered by Naked Eye were outstanding. They have made significant in-roads in delivering on our core brand strategy. We have been able to bring these consumers to life to both internal and external stakeholders and drive behaviour change."

— GSK, Global Marketing Director

"Naked Eye are a passionate bunch - we like them. They cared about the work, understood the issues and brought us great insights into our audience which we shared across our organisation."

— Pearson, Global Director, Immersive learning

"The VR got excellent feedback. We used two headsets at the media event and several journalists tested them out. We’re planning to use them internally with employees around disease awareness initiatives and take them to Congress in November. It’s been well worth doing."

— Director, Communications and Government Affairs
Global pharmaceutical company